These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 28709466

  • 1. Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
    Nenna R, Midulla F, Lambiase C, De Castro G, Zicari AM, Indinnimeo L, Cimino G, Troiani P, Quattrucci S, Tancredi G.
    Ital J Pediatr; 2017 Jul 15; 43(1):60. PubMed ID: 28709466
    [Abstract] [Full Text] [Related]

  • 2. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT, National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group.
    N Engl J Med; 2006 Jan 19; 354(3):229-40. PubMed ID: 16421364
    [Abstract] [Full Text] [Related]

  • 3. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD, ISIS Study Group.
    JAMA; 2012 Jun 06; 307(21):2269-77. PubMed ID: 22610452
    [Abstract] [Full Text] [Related]

  • 4. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK.
    J Trop Pediatr; 2012 Oct 06; 58(5):375-81. PubMed ID: 22374985
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.
    Dellon EP, Donaldson SH, Johnson R, Davis SD.
    Pediatr Pulmonol; 2008 Nov 06; 43(11):1100-1106. PubMed ID: 18828160
    [Abstract] [Full Text] [Related]

  • 6. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.
    Pediatr Pulmonol; 1996 Feb 06; 21(2):77-83. PubMed ID: 8882210
    [Abstract] [Full Text] [Related]

  • 7. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M, SHIP Study Group.
    Lancet Respir Med; 2019 Sep 06; 7(9):802-809. PubMed ID: 31178421
    [Abstract] [Full Text] [Related]

  • 8. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 06; 27(2):133-7. PubMed ID: 23745525
    [Abstract] [Full Text] [Related]

  • 9. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P, Balkovec S, Solomon M, Ratjen F.
    Pediatr Pulmonol; 2007 May 06; 42(5):471-6. PubMed ID: 17436328
    [Abstract] [Full Text] [Related]

  • 10. The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
    Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Hinckley Stukovsky KD, Dasiewicz A, Stick SM, SHIP-CT Study Group.
    Lancet Respir Med; 2022 Jul 06; 10(7):669-678. PubMed ID: 35286860
    [Abstract] [Full Text] [Related]

  • 11. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A, Conese M, Gambazza S, Biffi A, Tirelli AS, Russo M, Foà M, Colombo C.
    J Aerosol Med Pulm Drug Deliv; 2016 Dec 06; 29(6):482-489. PubMed ID: 27149365
    [Abstract] [Full Text] [Related]

  • 12. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.
    N Engl J Med; 2006 Jan 19; 354(3):241-50. PubMed ID: 16421365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F.
    Thorax; 2010 May 19; 65(5):379-83. PubMed ID: 20435858
    [Abstract] [Full Text] [Related]

  • 15. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M, Wielpütz MO, Ricklefs I, Dopfer C, Barth S, Schlegtendal A, Graeber SY, Sommerburg O, Diekmann G, Hüsing J, Koerner-Rettberg C, Nährlich L, Dittrich AM, Kopp MV, Mall MA.
    Am J Respir Crit Care Med; 2019 May 15; 199(10):1238-1248. PubMed ID: 30409023
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
    Anuradha KWDA, Gunathilaka PKG, Wickramasinghe VP.
    Pediatr Pulmonol; 2021 Feb 15; 56(2):509-515. PubMed ID: 33295693
    [Abstract] [Full Text] [Related]

  • 17. Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
    San Miguel-Pagola M, Reychler G, Cebrià I Iranzo MA, Gómez-Romero M, Díaz-Gutiérrez F, Herrero-Cortina B.
    Physiotherapy; 2020 Jun 15; 107():243-251. PubMed ID: 32026826
    [Abstract] [Full Text] [Related]

  • 18. The interrupter technique to assess airway responsiveness in children with cystic fibrosis.
    Davies PL, Doull IJ, Child F.
    Pediatr Pulmonol; 2007 Jan 15; 42(1):23-8. PubMed ID: 17106902
    [Abstract] [Full Text] [Related]

  • 19. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE, Godovchik JE, Donn KH, Busick DR, Goralski J, Locke LW, Markovetz MR, Myerburg MM, Muthukrishnan A, Weber L, Lacy RT, Pilewski JM.
    Pediatr Pulmonol; 2017 Sep 15; 52(9):1142-1149. PubMed ID: 28737262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.